Principal Technologies closes third financing round
Analysis based on 7 articles · First reported Jul 16, 2026 · Last updated Jul 24, 2026
The financing provides Principal Technologies with additional capital to advance its licensed technology, but the small size ($312,000) limits immediate market impact. The related party transaction may raise governance concerns among minority shareholders.
Principal Technologies Inc., a Canadian healthcare technology acquisition company, completed the third round of financing under its Licence of Technology Agreement with Oxford University Innovation. The company issued 416,000 common shares at $0.75 per share for gross proceeds of $312,000. The proceeds will fund R&D obligations under the licence and for general corporate purposes. Significant shareholder Roman Leydolf purchased all shares in a related party transaction exempt from formal valuation and minority approval under MI 61-101. The TSX Venture Exchange provided conditional acceptance, with final acceptance pending.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard